Compare RYAM & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAM | ETON |
|---|---|---|
| Founded | 1926 | 2017 |
| Country | United States | United States |
| Employees | 2325 | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.8M | 689.8M |
| IPO Year | 2014 | 2018 |
| Metric | RYAM | ETON |
|---|---|---|
| Price | $8.73 | $32.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $14.00 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 907.6K | 373.4K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $1,466,397,000.00 | $79,950,000.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | $8.22 | $47.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $3.35 | $13.09 |
| 52 Week High | $11.85 | $35.66 |
| Indicator | RYAM | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 41.88 | 63.63 |
| Support Level | $8.15 | $16.17 |
| Resistance Level | $8.80 | N/A |
| Average True Range (ATR) | 0.44 | 1.90 |
| MACD | -0.05 | 0.28 |
| Stochastic Oscillator | 23.37 | 62.14 |
Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.